Plasma CellsMultiple MyelomaBone MarrowBone Marrow TransplantationParaproteinemiasBone Marrow CellsTransplantation, AutologousTransplantation, HomologousPrognosisFlow CytometryHematopoietic Stem Cell TransplantationParaproteinsB-LymphocytesBone and BonesGraft vs Host DiseaseTransplantation ConditioningLiver TransplantationWhole-Body IrradiationAmyloidosisBone Marrow PurgingHematopoietic Stem CellsGraft SurvivalStem Cell TransplantationMelphalanLeukemiaKidney TransplantationTransplantation ChimeraAnemia, AplasticCyclophosphamideBusulfanCombined Modality TherapyBone Marrow DiseasesTreatment OutcomeTissue DonorsBone Marrow ExaminationRecurrenceHematopoiesisLeukemia, Plasma CellRemission InductionBone RemodelingLymphoma, Non-HodgkinBone Marrow NeoplasmsTime FactorsHistocompatibility TestingTransplantation, IsogeneicHematologic NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsMice, Inbred C57BLHematopoietic Stem Cell MobilizationHistocompatibilityHeart TransplantationAntigens, CD34Immunosuppressive AgentsPeripheral Blood Stem Cell TransplantationSurvival AnalysisLeukemia, Myeloid, AcuteGraft RejectionCarmustineGranulocyte Colony-Stimulating FactorRetrospective StudiesColony-Forming Units AssayThalidomideCell DifferentiationLung TransplantationRadiation ChimeraTransplantation ImmunologyCell TransplantationBone DensityDisease-Free SurvivalSurvival RateCells, CulturedSalvage TherapyBoronic AcidsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic SyndromesPyrazinesBone ResorptionFollow-Up StudiesMyeloma ProteinsT-LymphocytesImmunosuppressionPrecursor Cell Lymphoblastic Leukemia-LymphomaEtoposideOrgan TransplantationCytarabineGraft vs Tumor EffectLymphomaLeukemia, MyeloidHodgkin DiseaseAcute DiseaseLymphocyte DepletionCell SeparationHepatic Veno-Occlusive DiseaseBone DiseasesAntibodies, MonoclonalGraft vs Host ReactionBone NeoplasmsSpleenHLA AntigensAntigens, CD